Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Clinical trial NCT03425526 · RECRUITING
Trial details
- NCT number
- NCT03425526
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2027-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.